Osteoarthritis

Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial

Lancet RheumatolPublished Randomised controlled trial

Primary result · Hip pain severity (NRS 0-10), mean improvementResult — go to the resultMean difference 0.3 95% CI −0.3 to 0.8

Authors' conclusion

Despite improvement in pain and function in both groups, adding moderate-intensity aerobic physical activity to resistance exercise did not lead to superior outcomes.

Study context

Population
People with a clinical diagnosis of symptomatic hip OA, Melbourne, Australia134 [68%] women, 62 [32%] men
Participants
196 people
Comparison
Aerobic physical activity plus resistance exercise vs resistance exercise only
  • AEROBIC + RESISTANCEn = 97
  • RESISTANCE ONLYn = 99reference
Primary endpoint
Co-primary: change in hip pain severity (NRS 0-10, higher worse) and function (WOMAC 0-68, higher worse)
Follow-up
3 months
Methodological detailscomparative effectiveness, web-based randomisation (1:1), People with lived experience of hip OA involved in study design
  • Comparative effectiveness
  • Web-based randomisation (1:1)
  • People with lived experience of hip OA involved in study design

Primary result

Hip pain severity (NRS 0-10), mean improvement

Mean difference

0.3

95% CI −0.3 to 0.8

P = 0.36

Change by group

Aerobic + resistance

2.4

mean · SD 1.9

Resistance only

2.2

mean · SD 2.1

Aerobic + resistancevs Resistance only
mean difference 0.3 (95% CI −0.3 to 0.8); P = 0.36

As reported in the abstract

Further findings

Mean

OutcomeAEROBIC + RESISTANCERESISTANCE ONLYMean difference (95% CI)P value
Co-primary: function (WOMAC 0-68), mean improvement · 3 monthsIntention-to-treat7.0 (SD 10.4)8.9 (SD 10.8)−0.9 (−3.6 to 1.8)P = 0.51

Safety

Events

OutcomeAEROBIC + RESISTANCERESISTANCE ONLY
Related adverse eventsNone of which were serious2431

Original publication

Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial. Lancet Rheumatol. Published 5 February 2025. doi:10.1016/s2665-9913(24)00373-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.